BIOTECHNOLOGY - AN INTRODUCTION TO RECOMBINANT-DNA TECHNOLOGY AND PRODUCT AVAILABILITY

被引:9
作者
EVENS, RP
WITCHER, M
机构
[1] AMEGEN INC,DEPT PROFESS SERV,THOUSAND OAKS,CA 91320
[2] UNIV SO CALIF,SCH PHARM,LOS ANGELES,CA 90089
关键词
BIOTECHNOLOGY; RECOMBINANT DNA TECHNOLOGY; BIOLOGICAL PRODUCTS;
D O I
10.1097/00007691-199312000-00011
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Exciting advances in biotechnology have led to the development of innovative biological products to improve health care. In this review article, the major techniques of product development and manufacturing in biotechnology are discussed, with a focus on recombinant DNA technology. In addition, monoclonal antibody, nucleotide blockade, polymerase chain reaction, antisense, and gene therapy technologies will be defined briefly. For recombinant-DNA technology, the issues of gene isolation, gene cloning, protein expression, scale-up (manufacturing), and quality assurance are addressed. The 16 approved products and the research pipeline are characterized. In addition, major usage issues for biological products are noted. This review serves as an introduction to the science and applications of biotechnology present and future.
引用
收藏
页码:514 / 520
页数:7
相关论文
共 13 条
[1]   BIOPHARMACEUTICALS GO TO MARKET - PATTERNS OF WORLDWIDE DEVELOPMENT [J].
BIENZTADMOR, B .
BIO-TECHNOLOGY, 1993, 11 (02) :168-&
[2]  
BURRILL GS, 1991, BIOTECH 92 PROMISE R
[3]   TRACKING TRENDS IN UNITED-STATES BIOTECHNOLOGY [J].
DIBNER, MD .
BIO-TECHNOLOGY, 1991, 9 (12) :1334-&
[4]   INTO THE 21ST-CENTURY [J].
DREWS, J .
BIO-TECHNOLOGY, 1993, 11 (03) :S16-+
[5]  
GOLDSPIEL BR, 1993, CLIN PHARMACY, V12, P488
[6]   BACK TO THE FUTURE - BIOTECH PRODUCT SALES 1983-1993 [J].
KLAUSNER, A .
BIO-TECHNOLOGY, 1993, 11 (03) :S35-&
[7]  
LIPNER M, 1992, ONCOL TIMES, P14
[8]  
MILLER L, 1992, BIOTECHNOLOGY IND EV
[9]  
NAGEL KM, 1993, PHARMACOTHERAPY, V13, P177
[10]   CURRENT STATE OF THE HYBRIDOMA TECHNOLOGY [J].
PIROFSKI, L .
JOURNAL OF CLINICAL IMMUNOLOGY, 1990, 10 (06) :S5-S14